Statistics
Publications
1
Citations
15
H-Index
1
Active since
2022
Affiliations
University of California San Diego(Current)
Lyndsay Watkins is an author at University of California San Diego specializing in cancer pharmacology, multiple myeloma, and apoptosis resistance.
Publications per year
2022–2022
1
1
Ponatinib sensitizes myeloma cells to MEK inhibition in the high-risk VQ model
Evan Flietner, Zhi Wen, Adhithi Rajagopalan et al. · Scientific Reports · 2022 · 15 citations · Full text
Medicine, Oncology, Pharmacology +17
1–1 of 1